• No results found

[PDF] Top 20 Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema

Has 10000 "Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema" found on our website. Below are the top 20 most common "Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema".

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema

... YB colour vision ...smallest colour thresholds correspond to ~ 20 years of age and are followed by a gradual, linear increase of ~ 1% per year for RG and ~ ... See full document

15

<p>Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study</p>

<p>Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept &ndash; A Retrospective Cohort Study</p>

... in patients with DME prior to the introduction of anti – vascular endothelial growth factor (anti – ...visual acuity (VA) of 8.0 Early Treatment Diabetic Retinopathy Study (ETDRS) letters versus ... See full document

9

&lt;p&gt;Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia&lt;/p&gt;

<p>Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia</p>

... educate patients on lifestyle modi fi cations such as diet and the systemic control of comorbidities, for instance, hypertension and hypercholesterolemia along with glucose ...however, patients had a low ... See full document

9

Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial

Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial

... induced changes are yet to be fully ...ultrastructural changes to the trabecular meshwork resulting in greater resistance in the aqueous humour outflow tract ...of vision improve- ment by IVTA than ... See full document

5

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study

... An oedema index can be derived for each pixel, which is sensitive to oedematous changes of the ...these oedema indices gives a measure of the location and extent of retinal ...the macular ... See full document

6

&lt;p&gt;Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema&lt;/p&gt;

<p>Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema</p>

... methasone implant in refractory diabetic macular oedema (DMO) in real life ...22 patients that required treatment with single or multiple intravitreal dexamethasone ... See full document

8

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema

... ing intravitreal injections of any drug, macular laser treatments and vitrectomy), but could have had previous peripheral scatter retinal laser at the time of their first injection of ranibizumab and ... See full document

7

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review

... Age-related macular degeneration; BGV: Bilateral good vision; BSE: Better-seeing eye; CINAHL: Cumulative Index of Nursing and Allied Health Literature; DMO: Diabetic macular oedema; DR: ... See full document

13

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

... macula oedema of >250um. Post-FAc implantation, patients continued to be seen regularly to evaluate efficacy and safety, and to monitor associated retinopathy and other ocular ...all ... See full document

7

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema

... for diabetic macular oedema (DME) following fluocinolone acetonide (FAc) ...all patients with DME treated with FAc at a single centre were ...amplitude changes measured at each visit ... See full document

6

Real-world assessment of intravitreal dexamethasone implant (0.7&amp;nbsp;mg) in patients with macular edema: the CHROME study

Real-world assessment of intravitreal dexamethasone implant (0.7&nbsp;mg) in patients with macular edema: the CHROME study

... DeX implant. Missing data points resulted from lack of baseline visual acuity in the medical chart or lack of follow-up at a minimum of 12±2 weeks after the last DeX ...as vision was analyzed after ... See full document

14

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections

... some patients in the current study were not treatment-naïve, and may have undergone prior intravitreal injections of other agents or laser photocoagulation, although there was a six-month wash- out ... See full document

9

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis

... included patients with a vitreous haze score greater than + ...20/630. Patients were allowed to use certain topical and systemic medications during the trial if they had been stable on the medication prior ... See full document

9

Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies

Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies

... the vision- specific ...(near vision activities, distance vision activities, vision-specific social functioning, role difficulties, dependency, and mental health) was selected to develop a ... See full document

9

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema

... VA, macular thickness and macular volume, while baseline VA and macular thickness were not found to affect the RetTSQ ...Therefore, patients’ perceived satisfaction was based on their final VA ... See full document

8

Comparison of safety and efficacy of single dose intravitreal injection of triamcinolone acetonide 1 0 mg versus dexamethasone 0 7 mg intravitreal implant in patients with macular edema due to retinal vein occlusion

Comparison of safety and efficacy of single dose intravitreal injection of triamcinolone acetonide 1 0 mg versus dexamethasone 0 7 mg intravitreal implant in patients with macular edema due to retinal vein occlusion

... the dexamethasone intravitreal ...Implantable dExamethasone in Retinal Vein Occlusion with Macular Edema (GENEVA) Trials were two Phase III trials comparing the effects of intraocular ... See full document

6

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone

... visual acuity (BCVA) measured using the standardized Early Treatment Diabetic Retinopathy Study ...central macular thickness (CMT) and improve- ment of ocular ... See full document

8

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema

... good vision in patients with higher BCVA at baseline, while those with poorer starting vision have greater capacity to achieve clinically meaningful visual gains over the course of ...to ... See full document

8

Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients

Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients

... after injection, the mean IOP remained statistically significantly above base line ...minutes post- injection, nine patients ...those patients (with a 30 minute value of 28 mmHg) ... See full document

6

Early changes in macular optical coherence tomography parameters after Ranibizumab intravitreal injection in patients with exsudative age-related macular degeneration

Early changes in macular optical coherence tomography parameters after Ranibizumab intravitreal injection in patients with exsudative age-related macular degeneration

... Campinas. Patients older than 50 years of age, with BCVA between 20/40 and 20/320, determined by ETDRS chart, and primary choroidal neovasculari- zation associated with AMD (type 2) were ...included. ... See full document

5

Show all 10000 documents...